We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$14B
AUM Growth
-$163M
Cap. Flow
-$588M
Cap. Flow %
-4.21%
Top 10 Hldgs %
55.46%
Holding
59
New
12
Increased
13
Reduced
11
Closed
9

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$1.12B
2
ABBV icon
AbbVie
ABBV
+$416M
3
HRI icon
Herc Holdings
HRI
+$365M
4
LH icon
Labcorp
LH
+$171M
5
FLEX icon
Flex
FLEX
+$116M

Sector Composition

Rank Sector Weight
1 Healthcare 52.98%
2 Communication Services 11.74%
3 Materials 7.75%
4 Technology 6.93%
5 Industrials 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
1
Humana
HUM
$43.5B
$1.69B 12.06%
9,529,175
+860,926
+10% +$149M
HCA icon
2
HCA Healthcare
HCA
$86.7B
$1.21B 8.65%
15,988,990
+1,401,998
+10% +$107M
CI icon
3
Cigna
CI
$72.2B
$781M 5.58%
5,991,396
-114,727
-2% -$15M
PARA
4
DELISTED
Paramount Global Class B
PARA
$739M 5.29%
13,500,427
+6,202,089
+85% +$329M
ELV icon
5
Elevance Health
ELV
$81.7B
$701M 5.02%
5,597,242
+1,637,826
+41% +$211M
AET
6
DELISTED
Aetna Inc
AET
$598M 4.28%
5,179,716
LH icon
7
Labcorp
LH
$25.2B
$579M 4.14%
4,902,798
-1,448,655
-23% -$171M
FLEX icon
8
Flex
FLEX
$47.2B
$531M 3.8%
51,713,972
-11,979,946
-19% -$116M
FMC icon
9
FMC
FMC
$1.3B
$503M 3.6%
12,009,100
-576,500
-5% -$23.8M
TMO icon
10
Thermo Fisher Scientific
TMO
$209B
$427M 3.06%
2,686,316
-171,924
-6% -$26.5M
THC icon
11
Tenet Healthcare
THC
$20.4B
$405M 2.9%
17,890,230
CSC
12
DELISTED
Computer Sciences
CSC
$399M 2.85%
7,641,847
+762,557
+11% +$36.8M
ABBV icon
13
AbbVie
ABBV
$432B
$380M 2.72%
6,030,141
-6,424,347
-52% -$416M
DD icon
14
DuPont de Nemours
DD
$19.1B
$306M 2.19%
2,330,266
+171,220
+8% +$22.8M
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$4.65T
$299M 2.14%
7,436,980
EHC icon
16
Encompass Health
EHC
$11B
$291M 2.08%
9,012,413
BKD icon
17
Brookdale Senior Living
BKD
$3.43B
$290M 2.08%
16,630,415
CAR icon
18
Avis
CAR
$4.95B
$284M 2.03%
8,298,004
IQV icon
19
IQVIA
IQV
$37.5B
$274M 1.96%
3,381,622
+1,462,067
+76% +$111M
HTZ
20
DELISTED
Hertz Global Holdings, Inc.
HTZ
$265M 1.9%
+7,599,786
New +$318M
WMB icon
21
Williams Companies
WMB
$88.4B
$259M 1.85%
8,438,558
+1,305,876
+18% +$34.7M
IMS
22
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
$233M 1.66%
7,426,648
+667,580
+10% +$19.5M
MAN icon
23
ManpowerGroup
MAN
$2.53B
$207M 1.48%
2,870,015
-648,179
-18% -$44.7M
CHTR icon
24
Charter Communications
CHTR
$18.1B
$182M 1.3%
672,597
-353,850
-34% -$89.4M
LBTYK icon
25
Liberty Global Class C
LBTYK
$3.6B
$176M 1.26%
5,320,677

Similar funds

Glenview Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Glenview Capital Management held 59 positions worth $14B, down 1.1% from $14.1B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Glenview Capital Management withdrew a net $588M in Q3 2016, closing 9 positions and reducing 11 holdings. Its most notable exit was Monsanto Co, an estimated $1.12B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 51% a quarter earlier, followed by Communication Services and Materials.

Against the trend, Glenview Capital Management opened a new position in Hertz Global Holdings, Inc. worth $265M.

  • Glenview Capital Management's largest Q3 2016 buy was Hertz Global Holdings, Inc.: 7,599,786 shares worth $265M.
  • Glenview Capital Management added most to Paramount Global Class B in Q3 2016, an estimated $329M increase.
  • Glenview Capital Management's biggest Q3 2016 reduction was AbbVie, cutting an estimated $416M.
  • Glenview Capital Management fully exited Monsanto Co in Q3 2016, selling an estimated $1.12B.
  • Glenview Capital Management's ten largest holdings make up 55% of its $14B portfolio in Q3 2016.
  • Glenview Capital Management opened 12 new positions and closed 9 in Q3 2016.
  • Glenview Capital Management's portfolio value fell 1.1% quarter-over-quarter to $14B.

Based on Glenview Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.